Zdrowie i gospodarka · 25/03/2011
FDA Extends Comment Period for National Antimicrobial Resistance Monitoring System Strategic Plan
The Food and Drug Administration (FDA) is extending the comment period for its notice on the National Antimicrobial Resistance Monitoring System (NARMS) Strategic Plan 2011-2015, allowing interested persons more time to submit comments, following requests from stakeholders.